Highlights | | Follow us on LinkedIn | Join our community on LinkedIn and stay updated with the latest and most exciting research. | |
| | | |
|
Table of Contents | | | | | Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo | Tian Zhang, Han Yin, Yu Li, Haiyin Yang, Kun Ge, Jinchao Zhang, Qing Yuan, Xuyan Dai, Abid Naeem, Yuhua Weng, Yuanyu Huang, Xing-Jie Liang | Drug delivery system; Nanoparticles; Nucleic acids | |
| | | | | | | | | | | | | Hallmarks of cancer resistance | Muhammad Tufail, Jia-Ju Hu, Jie Liang, Cai-Yun He, Wen-Dong Wan, Yu-Qi Huang, Can-Hua Jiang, Hong Wu, Ning Li | Health sciences; Microenvironment; Biological sciences; Molecular biology; Epigenetics; Cancer. | |
| | Overcoming barriers to improved decision-making for battery deployment in the clean energy transition | Brian Tarroja, Julie M. Schoenung, Oladele Ogunseitan, Alissa Kendall, Yang Qiu, Timothy Malloy, Jens Peters, J. Mijin Cha, Dustin Mulvaney, Oliver Heidrich, Manuel Baumann | Electrochemical energy storage; Energy policy; Engineering | |
| | | | | DHCR24 inhibitor SH42 increases desmosterol without preventing atherosclerosis development in mice | Xiaoke Ge, Bram Slütter, Joost M. Lambooij, Enchen Zhou, Zhixiong Ying, Ceren Agirman, Marieke Heijink, Antoine Rimbert, Bruno Guigas, Johan Kuiper, Christoph Müller, Franz Bracher, Martin Giera, Sander Kooijman, Patrick C.N. Rensen, Yanan Wang, Milena Schönke | Cardiovascular medicine; Cellular physiology; Molecular genetics | |
| | | | | | |
|
|